C. Jan Willem Borleffs

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.7K citations · Full text

Medicine, Cardiology, Pharmacology +17

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink et al. · Nature Medicine · 2022 · 895 citations · Full text

Medicine, Cardiology, Pharmacology +15

Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator

Stijntje D. Roes, C. Jan Willem Borleffs, Rob J. van der Geest et al. · Circulation Cardiovascular Imaging · 2009 · 460 citations · Full text

Medicine, Cardiology, Radiology +17

Inappropriate Implantable Cardioverter-Defibrillator Shocks

Johannes B. van Rees, C. Jan Willem Borleffs, Míhàly K. de Bie et al. · Journal of the American College of Cardiology · 2011 · 446 citations

Medicine, Cardiology, Clinical Cardiology +10

Long-Term Prognosis After Cardiac Resynchronization Therapy Is Related to the Extent of Left Ventricular Reverse Remodeling at Midterm Follow-Up

Claudia Ypenburg, Rutger J. van Bommel, C. Jan Willem Borleffs et al. · Journal of the American College of Cardiology · 2009 · 436 citations

Medicine, Cardiology, Clinical Cardiology +5